|Articles|September 7, 2021

A Different Kind of Trial for This Attorney – Brad Hertz Enrolls in a Prostate Cancer Clinical Trial

Brad Hertz is a BRCA2 previvor who enrolled himself in a clinical trial for prostate cancer.

Clinical trials and research studies are how we move science and research forward. During Prostate Cancer Awareness Month we honor all those with, or at risk for, prostate cancer and we share this story of Brad Hertz, BRCA2 previvor who enrolled himself in a prostate cancer clinical trial at the National Institutes of Health.

https://facingourrisk.org/blog/a-different-kind-of-trial-a-litigation-attorneys-take-on-being-in-a-national-institutes-of-health-clinical-trial/?utm_source=CURE&utm_medium=website

Stay up to date on cancer updates, research and education

A Different Kind of Trial for This Attorney – Brad Hertz Enrolls in a Prostate Cancer Clinical Trial

Trending on CURE

5-Year Data Support Personalized Vaccine in High-Risk Melanoma

Mariska Hargitay Honors Father Through Myeloma Awareness Effort

Experimental Treatment Shrinks Tumors in Aggressive Adenoid Cystic Carcinoma

Monjuvi, Revlimid Combo May Help Prevent Diffuse Large B-Cell Lymphoma Relapse

Trodelvy Plus Keytruda Shows Lasting Benefit in Metastatic Breast Cancer